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http://dx.doi.org/10.1016/j.stemcr.2016.05.014SUMMARYReprogramming to pluripotency after overexpression of OCT4, SOX2, KLF4, and MYC is accompanied by global genomic and epige-
nomic changes. Histone modification and DNA methylation states in induced pluripotent stem cells (iPSCs) have been shown to be
highly similar to embryonic stem cells (ESCs). However, epigenetic differences still exist between iPSCs and ESCs. In particular, aberrant
DNA methylation states found in iPSCs are a major concern when using iPSCs in a clinical setting. Thus, it is critical to find factors that
regulate DNA methylation states in reprogramming. Here, we found that the miR-29 family is an important epigenetic regulator during
human somatic cell reprogramming. Our global DNA methylation and hydroxymethylation analysis shows that DNA demethylation
is a major event mediated by miR-29a depletion during early reprogramming, and that iPSCs derived frommiR-29a depletion are epige-
netically closer to ESCs. Our findings uncover an important miRNA-based approach to generate clinically robust iPSCs.INTRODUCTION
Overexpression of four transcription factors (OCT4, SOX2,
KLF4, and MYC) reprograms differentiated cells to become
induced pluripotent stem cells (iPSCs). The global epige-
nomic changes that accompany reprogramming include
histone modification, DNA methylation, expression of
non-coding RNAs, and reactivation of the inactive X chro-
mosome (Kim et al., 2014; Papp and Plath, 2013). iPSCs
maintain the genetic composition of donor cells, and
thus have been proposed to model human diseases
in vitro through differentiation into target cell types. In
addition, iPSCs can provide autologous cells for cell
replacement therapy (Wu and Hochedlinger, 2011). How-
ever, studies have shown that iPSCs contain localized aber-
rant epigenetic states compared with human embryonic
stem cells (hESCs) despite their high similarity (Bock
et al., 2011; Lister et al., 2011). Understanding the reprog-
ramming mechanisms and developing novel reprogram-
ming technologies to minimize the abnormality of iPSCs
are critical for the future use of iPSCs.
Among the epigenetic aberrations of iPSCs, DNAmethyl-
ation is of particular importance. Previous studies showed
that unique de novo differentially methylated (DMR) or
hydroxymethylated regions (hDMR) are present in iPSCs
compared with hESCs (Lister et al., 2011; Wang et al.,Ste
This is an open access article under the C2013). Furthermore, the retention of the epigenetic mem-
ory of donor cell types via cell-type-specific methylation
affects the differentiation potential of iPSCs (Kim et al.,
2011). There are three major enzymes that mediate DNA
methylation. De novo DNA methyltransferases (DNMT3A
and DNMT3B) are responsible for transferring a methyl
moiety from S-adenosyl-methionine to cytosine to make
5-methylcytosine (5mC). DNMT1 together with hemi-
methylated DNA-binding protein UHRF1 maintain 5-mC
during cell-cycle progression (Jones, 2012). DNA demethy-
lation, on the other hand, is either passive or indirect in
mammalian cells. It has been shown to be mediated by en-
zymes recruited during base or nucleotide excision DNA
repair responses, as well as by cytidine deaminases (Wu
and Zhang, 2010). Ten-eleven translocation proteins
(TET1, TET2, and TET3) belonging to the family of 2-oxo-
glutarate- and iron (II)-dependent dioxygenases were also
identified as DNA demethylation proteins (Kriaucionis
and Heintz, 2009; Tahiliani et al., 2009). TETs were shown
to catalyze the oxidation of 5mC into 5-hydroxymethylcy-
tosine (5hmC) (Kriaucionis and Heintz, 2009; Tahiliani
et al., 2009). TETs further convert 5-hmC to formylcytosine
(5fC) and carboxycytosine (5caC), which undergo base
excision repair by thymine-DNA glycosylase (TDG) (Ito
et al., 2011; Shen and Zhang, 2013). Whereas 5mC is en-
riched in promoter regions of silent genes, 5mC in them Cell Reports j Vol. 7 j 43–54 j July 12, 2016 j ª 2016 The Author(s). 43
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gene body is positively correlated with gene expression
(Ball et al., 2009; Lister et al., 2009). In contrast, 5hmC in
both the promoter and gene body is associated with pro-
moting gene expression (Song et al., 2011).
MicroRNAs, or miRNAs, are a family of small 22 nt
RNAs that regulate gene expression at themRNA or protein
level, and with functional implications in a wide range of
biological processes (Bartel, 2004). miRNAs are extensively
studied for their cell- and tissue-specific roles in cancer
where they are significant contributors to epigenetic land-
scaping (Croce, 2009). The function of miRNAs was also
explored in the context of somatic cell reprogramming. It
was found that the miRNA 290–295 cluster is highly ex-
pressed in ESCs (Marson et al., 2008), and could enhance
reprogramming efficiency in combination with Oct4,
Sox2, and Klf4 (Judson et al., 2009; Nakagawa et al.,
2008). It was also shown thatmiRNA cluster 302–367 (Ano-
kye-Danso et al., 2011), or the cocktail miR-200c, miR-302,
and miR-369 (Miyoshi et al., 2011) alone, could success-
fully reprogram both human and mouse cells to pluripo-
tency, although efficiency is low (Lu et al., 2012). A diverse
number of miRNA targeting processes such as mesen-
chymal-epithelial transition, apoptosis, and senescence,
have been characterized and shown to modulate reprog-
ramming in combination with the classical transcription
factors (Bao et al., 2013). The miR-29 family, comprising
miR-29a, miR-29b1, and miR-29c, is aberrantly expressed
in various cancers, plays a role in extracellular matrix
(ECM) production and fibrosis, and has also been shown
to target DNAmethylation enzymes Dnmt3a and Dnmt3b
(Fabbri et al., 2007; Roderburg et al., 2011; Suh et al., 2012;
Yang et al., 2013). More recently, with the help of our col-
laborators and others, we have shown that miR-29a also
targets the TET protein family and TDG that convert
5mC to 5hmC and C (Cheng et al., 2013; Yang et al.,
2013). Furthermore, miR-29 levels are high in senescent
cells (Martinez et al., 2011) and repressed in the presence
of Myc (Chang et al., 2008). Downregulation of miR-29a
also showed some improvement of reprogramming effi-
ciency in mouse fibroblasts, but its role in human reprog-
ramming remains unexplored (Yang et al., 2011).
Given the significance of methylation/demethylation
during reprogramming, we set out to investigate the
function of miR-29a in regulating the iPSC methylome.
Although miR-29a was shown to directly regulate both de
novo DNAmethyltransferases and demethylases, we found
thatdepletionofmiR-29a resulted inDNAdemethylation in
fibroblasts, suggesting that the major targets of miR-29a
in somatic cells are DNA demethylases. Interestingly, and
in support of our study, miR-29a targets TETs and TDG
were recently shown to impair reprogramming ofmurine fi-
broblasts when downregulated, due to the block of miRNA-
mediated mesenchymal-to-epithelial transition that is44 Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016required for reprogramming (Hu et al., 2014). More impor-
tantly, iPSC lines derived from miR-29a depletion partly
overcome the aberrant DNA methylation status observed
incontrol-derived iPSCandresemblehESCs in theirmethyl-
ome. Our study facilitates the understanding of the role of
small RNAs in modulating the iPSC epigenome.RESULTS
The miR-29 Family Regulates Proteins Involved in
DNA Methylation
Because our previous works and others have shown that
iPSCs undergo global DNA methylation/hydroxymethyla-
tion changes, we reasoned that miR-29 plays critical roles
in regulating epigenetic changes during reprogramming
(Doi et al., 2009; Lister et al., 2011). First, we confirmed
the in silico targeting of 30 UTRs of DNMTs, TETs, and
TDG by miR-29 (Figure S1). Previous studies found that a
large number ofmiRNAs showdifferences in expression be-
tween pluripotent and differentiated cells (Morin et al.,
2008; Stadler et al., 2010).We found that themiR-29 family
is highly expressed in the human primary fibroblast line
Detroit 551 (D551), but low in human pluripotent cells,
including ESCs (H1, H9), iPSCs (BJ-iPSC, PGP1-iPSCs, and
D551-iPSCs), and human embryonic carcinoma cells
(NCCIT) (Figure 1A). Most of its known targets
(DNMT3A/3B and TET1/3) involved in DNA methylation
show an inverse expression pattern to that of miR-29
expression: low in fibroblasts (D551, MRC-5) and high in
pluripotent cells (Figure S2A). The luciferase reporter con-
taining the 30 UTR of TET1 further confirmed the direct
repression by miR-29a (Figure S2B). When the reporter
was used for unbiased screening to identify miRNAs
directly regulating TET1, we found miR-29a and miR-29b
were among the miRNAs that most strongly reduced the
activity of the reporter (Table S1). When examining cells
undergoing reprogramming, miR-29 expression decreased
while its targets (TET1/3, DNMT3A/B, TDG) increased
as the cells became pluripotent (Figures 1B and S2C).
Furthermore, treating fibroblasts with miR-29a inhibitor
increased, while miR-29a mimic decreased total genomic
levels of 5hmC, 5fC, and 5caC (Figure S2D). Although
Guo et al. (2013) reported that miR-29 family expression
increased during reprogramming and that miR-29b en-
hances iPSCs generation in mice, our data showed reduc-
tion of miR-29 family expression in humans. In addition,
we found that the expression level of miR-29b is signifi-
cantly lower than the other miR-29 family in fibroblasts
(Figure S2E), indicating the species difference of miRNA-
mediated iPSC reprogramming. These data suggest that
predicted and known targets of miR-29a may be tightly
regulated by this miRNA in pluripotency, reprogramming,
A B C
D E F G
miR-29ai
miR-29abc sp
m
iR
-2
9a
 in
h.
m
iR
-2
9a
 sp
.
m
iR
-2
9a
 in
h.
m
iR
-2
9a
 sp
.
miR-29abc sp
Figure 1. Functional Regulation of DNA Methylation Proteins by the miR-29 Family
(A) qPCR reveals that miR-29 family members are not expressed in pluripotent stem cells (ESCs H1, H9; iPSCs BJ1, PGP1, D551; embryonal
carcinoma cell line NCCIT) but highly expressed in fibroblasts (D551) (n = 3, independent experiments).
(B) The miR-29a family shows a decrease of expression during three- (OSK) and four-factor (OSKM) reprogramming. w1-w4 represent
samples collected for week 1 to week 4 after infection of reprogramming factors (n = 3, independent experiments).
(C) Overexpression of miR-29a antagomir (29ai) and miR-29 sponge (29a sp) increases expression of 141 genes and decrease expression of
100 genes (total RNA collected 3 days post-infection/transfection) (>1.5-fold change in both 29ai and 29a sp). Orange and blue bars
represent the false discovery rate (FDR) of GO terms in miR-29a-depleted and control cells, respectively. Dashed line represents the 0.05
FDR cutoff.
(D and E) Genes for (D) ECM proteins and (E) de novo DNA methylation and demethylation are among the top genes showing upregulation
in miR-29a-depleted cells. Ratios of log2-scaled expression values of miR-29a knockdown over control cells are shown by colors from blue
to red. + represents miR-29a targets predicted by TargetScan.
(F) Inhibition of miR-29 by a miR-29 sponge construct induces TET1/2/3, DNMT3A, and -3B, but not DNMT1, as validated by qRT-PCR (n = 3,
independent experiments).
(G) Comparative analysis of protein and RNA expression. The X and Y axes represent log2(29ai/Ctrli) of protein and RNA expression,
respectively. Genes showing differential expression between protein and RNA for ECM proteins (blue) and TDG (red) are shown.
*p < 0.05 by one-sided t test. Error bars represent the SD.and DNA methylation. We employed RNA sequencing
(RNA-seq) to examine the global gene expression changes
in cells depleted of miR-29. D551 fibroblasts were trans-
fected with miR-29a antagomir or infected with miR-29
sponge, and subsequently used for processing and analysis
(Figure S2F). miR-29 sponge and miR-29a antagomir simi-
larly affected global gene expression (Figure 1C). Genes
with predicted miR-29a target sequences at 30 UTR weresignificantly upregulated (Table S2, p = 4.013 1033 by hy-
pergeometric test). Gene ontology (GO) analysis showed
that ECMgenes are highly induced aftermiR-29a depletion
(Figures 1C and 1D). The predicted and tested targets of
miR-29a, including DNMT3A/B, TETs, and TDG, showed
upregulation upon miR-29a depletion, whereas DNMT1
level did not change significantly (Figures 1E and 1F). The
expression of pluripotency genes OCT4, SOX2, PRDM14,Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016 45
LIN28A, NANOG, and REX1 were not induced, suggesting
no effect in the core pluripotency network by miR-29a
depletion (Figures S2G and S2H). However, KLF4 showed
a slight increase after miR-29a depletion, with increasing
levels of 5hmC and 5mC in the promoter and gene body,
respectively (Figure S2I). Because miRNA regulates protein
expression via mRNA degradation or translation arrest,
we performed proteomics analysis to determine regulation
by miR-29a at the protein level. We confirmed that the
overall global protein expression is well correlated with
the mRNA expression change upon miR-29a depletion
(Figure 1G and Table S3). Furthermore, mRNA and protein
expression changes increase as the number of target sites
on the 30 UTR of target genes increases for several seed
matches, suggesting that the observed gene expression
changes come from the direct regulation by miR-29a (Fig-
ure S2J). Proteomics data identified the DNA methylation
regulator TDG as an upregulated protein after miR-29a
depletion (Figure 1G). Protein levels of other DNA methyl-
ation regulators appear to be under the detection limit of
this proteomics assay. Taken together, these data suggest
that miR-29a regulates the expression of genes involved
in DNA methylation regulation.
Depletion of the miR-29 Family Coordinates DNA
Methylation and Demethylation
To investigate the effect of miR-29a depletion on DNA
methylation regulation, we performed global DNAmethyl-
ome and hydroxymethylome using methylated and hy-
droxylmethylated DNA immunoprecipitation sequencing
((h)MeDIP-seq) in D551 cells transfected with miR-29a an-
tagomir. Overall, fibroblasts showed a limited number of
5hmC peaks, in contrast to the large number of 5hmC
peaks in human ESCs (Figure 2A). In addition, only a small
number of genes have overlapping hDMRs between miR-
29a-depleted fibroblasts and ESCs (Figure S3A). Surpris-
ingly, we found that miR-29a depletion significantly
increased the formation of 5hmC in SOX2 binding sites
but not in other reprogramming factor binding sites (Fig-
ure S3B) (Soufi et al., 2012). Chromatin immunoprecipita-
tion (ChIP)-qPCR analysis revealed that the increasing
level of SOX2 binding with 5hmC is caused by miR-29a
depletion (Figure S3C). These data suggest that changes
of the methylation status in SOX2-binding sites upon
miR-29a depletion may regulate the binding strength of
SOX2 to its targets during early reprogramming.
5mC displayed a more dramatic change after miR-29a
depletion. Whereas around 1,000 regions of hyper-differ-
entially methylated regions (hyper-DMRs) were detected,
over 7,000 regions of hypo-differentially methylated
regions (hypo-DMRs) were observed in miR-29a-depleted
cells (Figure 2A). Interestingly, 92.8% (6,565) of hypo-
DMRs in miR-29a-depleted cells overlapped with those in46 Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016human ESCs and are enriched in developmental genes (Fig-
ure S3D), suggesting that miR-29a depletionmodulates the
fibroblast methylation pattern primarily via DNA
demethylation (Figure 2B). Changes in gene body methyl-
ation were predominant in hyper- and hypo-DMRs for
both 5mC and 5hmC (Figure 2C). Through GO analysis
for the DMRs between control and miR-29a-depleted cells,
we found that genes involved in histone modification and
development of several lineages have lower 5mC levels in
miR-29a-depleted cells compared with controls, reflecting
epigenetic dynamics associated with miR-29a modulation
(Figure 2D). Although promoter methylation marks gene
suppression, gene body methylation is highly correlated
with gene activation (Ball et al., 2009; Lister et al., 2009).
Induction of hypo-methylation in the gene body of devel-
opmental genes by miR-29a depletion suggests that miR-
29a depletion represses the developmental genes and
thus facilitates the cell fate change. We also found slightly
higher 5hmC levels in miR-29a-depleted loci compared
with controls, but we could not identify significant GO
categories in the loci associated with these 5hmC gains.
Interestingly, when we compared the methylation profiles
of control versus miR-29a-depleted fibroblasts, many loci
resemble the methylation tracks found in the H1 human
ESC line (Figure 2E). A short 3-day depletion of miR-29a
appears to be sufficient to initiate more demethylation in
the promoter of the critical pluripotency marker NANOG.
Bisulfite sequencing showed that DNA methylation in
theNANOG locus was diminished by themiR-29a inhibitor
(Figure S3E, 34%–0%). In contrast, Cadherin 2 (CDH2), a
developmental gene not expressed in pluripotent stem
cells, gains de novomethylation peaks in its promoter (Fig-
ure 2E) (Su et al., 2013). Our results suggest that one major
role of miR-29a in differentiated cells is tomaintain the cell
fate by DNA methylation.
Next, we transduced fibroblasts individually with virus
expressing each DNA methylation-related protein, miR-29
sponge, OSKM, or individual O, S, K, M, and carried out
methylation analysis using Illumina’s 450K BeadChip. We
found a high similarity of methylated (higher ratio to con-
trol sample) and demethylated (low ratio to control sample)
regions between miR-29 sponge cells and OSKM and TET1/
2/3 transduced cells (Figures S3F and S3G). These data sup-
port the idea that the DNA demethylation upon miR-29a
depletion has a strong correlation with the regulation by
TET family proteins at an early time point in miR-29a-
depleted cells, even though the overall pattern ismost likely
a result of synergistic regulation of all miR-29 targets.
Depletion of the miR-29 Family Contributes to ESC-
Specific Transcriptome and Epigenetic Profile in iPSCs
Because depletion of the miR-29a family contributes to the
demethylation of fibroblast-specific DNAmarks (Figures 2A
A B
C D
E
Figure 2. DNA Methylation Changes in Fibroblasts after miR-29a Depletion
(A) The number of hyper- and hypo-DMRs in D551 fibroblasts depleted of miR-29a (antagomir-mediated, samples collected for MeDIP and
hMeDIP 3 days post-transfection) and human ESCs.
(B) Venn diagrams show overlap of hyper- and hypo-DMRs of 5hmC between miR-29a-depleted cells and human ESCs.
(C) The distribution of hyper- and hypo-DMRs of 5hmC and 5mC around the gene body and CpGI in miR-29a-depleted cells and human ESCs.
(D) GO analysis of 5mC- and 5hmC-enriched regions specific to control and miR-29ai. Venn diagrams show the number of genes regulated
by 5hmC and 5mC in miR-29a depleted and control cells. We did not detect any significant GO terms in genes regulated by 5hmC.
(E) NANOG undergoes demethylation and CDH2 undergoes methylation in miR-29a-depleted cells. These loci become similar to those in
human ESCs.and 2B), and a previous report showed that reprogramming
of murine somatic cells is improved via miR-29a depletion
(Yang et al., 2011), we tested whether depletion of miR-29a
affects the efficiency of reprogramming in human somaticcells, and whether it influences the epigenetic states in
iPSCs. We transfected human fibroblast cells with miR-
29a antagomir or mimic, or infected them with retrovirus
expressing the miR-29 sponge, and subsequently initiatedStem Cell Reports j Vol. 7 j 43–54 j July 12, 2016 47
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Figure 3. Regulation of Reprogramming by miR-29a Inhibition
(A) Inhibition of miR-29a using antagomir increases the reprogramming efficiency of human fibroblasts (D551) (n = 6, ***p < 0.003,
independent experiments), overexpression using miR-29a mimic decreases reprogramming (n = 6, ***p < 0.005), and sponge-dependent
miR-29 inhibition (retrovirus multiplicity of infection = 2.5) increases reprogramming efficiency (n = 3, *p < 0.02, independent
(legend continued on next page)
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reprogramming. Suppression of miR-29a by either antago-
mir or sponge increased reprogramming efficiency,
whereas overexpression of miR-29a mimic reduced it (Fig-
ure 3A), as assessed by quantifying alkaline-phosphatase-
stained colonies. We further scored the reprogramming
efficiency by staining colonies with pluripotency cell sur-
face marker TRA-160 (Figure S4A). The overexpression of
TET1 and DNMT3B also significantly increased reprogram-
ming efficiency (Figures S4B–S4D), suggesting that positive
regulation of reprogramming by depletion of miR-29a may
be due to the upregulation of these of DNA methylation-
related proteins. We found that DNMT3B and TET1 display
only demethylation (Figure S3G), whereas TET2/3 and
TDG introduce both methylation and demethylation in
developmental genes. Since it was previously reported
that miR-29a suppresses p53 (Yang et al., 2011), we also
tested whether the reprogramming effect by miR-29a in-
volves the p53 pathway. To this end, we reprogrammed hu-
man fibroblasts in the presence of miR-29a mimic alone,
p53 shRNA alone, or miR-29a mimic + p53 shRNA. We
found that reprogramming increases when p53 is depleted,
decreases when miR-29a is overexpressed, and does not
change in presence of both p53 depletion and miR-29a
mimic (Figure S4E). This suggests that either p53 is up-
streamofmiR-29a and its depletion is canceling themiRNA
effect, or the pathways are separate and their effects annul
each other.
Next, we asked whethermiR-29a depletion plays a role in
genetic and epigenetic regulation in reprogramming. We
derived human iPSC clones from D551 or fetal myoblast
line (FM-1) depleted of miR-29a through antagomir or
sponge construct, and performed transcriptome analysis
in these iPSC clones. 3D principal component analysis of
over 14,000 genes showed closer localization of miR-29a-
depleted iPSCs to the H1 and H9 ESC groups than the con-
trol counterparts (Figure 3B). Furthermore, we observed
separate clustering of control and miR-29a-depleted iPSCs
independently of parental cell origin (fibroblasts versus
myoblasts) and depletion method (antagomir versus
sponge) (Figure 3C). GO analysis of differentially expressed
genes revealed ECM organization genes overrepresented inexperiments). Left: quantification. Right: alkaline phosphatase (AP) s
miR-29a depletion or overexpression.
(B) Principal component analysis shows the similarity of ESCs (H1 an
fetal-myoblast-derived iPSCs.
(C) Left: Differentially expressed genes separating control versus miR
loading PC2 < 0.2 and PC3 > 0.2). Right: GO overrepresentation of
denotes FDR = 0.05.
(D and E) Average reads per kilobase per million values across all co
depleted cells and (E) genes high in control iPSCs. ESC-specific gene
iPSCs (miR29-D denotes miR-29 depletion) (n = 6, 8, 2 in Ctrl iPSC, m
Error bars represent the SD.miR-29a-depleted iPSCs, as expected due to many miR-29a
targets falling under this category (Figure 3C). Interest-
ingly, neuronal lineage regulators and the WNT pathway
are also enriched networks in miR-29a-depleted cells, sug-
gesting both an increase in the pluripotent program path-
ways (WNT) and modulation of the differentiation poten-
tial (neuronal/glial) of the iPSCs by this miRNA, despite
the non-neuronal cell of origin. Our group and others
have compared gene expression changes between human
ESCs and iPSCs and identified aberrantly expressed genes
in iPSCs (Huang et al., 2014; Lister et al., 2011; Ruiz et al.,
2012; Tanaka et al., 2013; Wang et al., 2013). We found
that most iPSC lines derived under miR-29a-depleted con-
ditions showed suppression of some iPSC-specific genes
and recovery of several ESC-specific genes (Figure 3D).
The most commonly identified ESC-specific genes
TCERG1L, FAM19A5, and TMEM132D, and others like
ZDHHC19 and HTR6, showed significant recovery in iPSC
lines derived from miR-29a depletion (Figures 3D and
S4F). Some iPSC-specific genes such as FBP2, CCR8,
FAM82A1, MGC16121, and SLC22A2, but not others like
ZNF454 and ZNF572, were suppressed in miR-29-depleted
cells (Figures 3E and S4G). These data suggest that the ma-
jor effect of miR-29a depletion is demethylation and leads
to high similarity with ESC state in hypo-DMRs (Figures 2A
and 2B).
In order to determine the methylation change in iPSC
lines derived frommiR-29a depletion, we performed global
DNA methylation analysis through MeDIP in ESCs and
iPSCs. Surprisingly, we found that iPSC lines with miR-29
depletion cluster with ESC lines for the transcription start
sites (TSS), CpG shore, and gene bodymethylation patterns
(Figure 4A). CpG islandmethylation showed no discernible
pattern, with the majority of iPSCs clustering separately
from ESCs. GO analysis for TSS and gene bodies revealed
methylation enrichment in loci involved in metabolic
and catabolic processes for ESCs and miR-29-depleted
iPSCs compared with control lines (Figures 4B and 4C).
Interestingly, at the CpGI shore level, we found depletion
of methylation in loci involved in lineage specification in
ESCs and miR-29-depleted iPSCs compared with controltaining of two representative wells. Reprogramming with OSKM and
d H9) with miR-29a-depleted D551 fibroblasts and iPSCs, and FM-1
-29 knockdown cells irrespective of parental cell of origin (factor
upregulated genes in miR-29a-depleted iPSCs. The dashed red line
ntrol and miR-29a-depleted iPSCs for (D) genes high in miR-29a-
s FAM19A5, TMEM132D, and TCERG1L increased in miR-29-depleted
iR29a-D iPSC, and ESC, respectively, independent experiments).
Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016 49
(legend on next page)
50 Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016
iPSCs (Figure 4D). Gene expression shows significant corre-
lation with methylome changes in TSS, gene body, and
CpGI shore, suggesting a functional relevance (Figure 4E).
Our finding is noteworthy, as DMRs that are present partic-
ularly at CpGI shores were distinct between different
somatic, cancer, and reprogrammed cell types, possibly
acting as cell identity marks (Doi et al., 2009).DISCUSSION
In this study, we set out to investigate the function of
miRNAs that regulate the epigenetic landscape in somatic
cells and thus may have a function in somatic cell reprog-
ramming. We found that the miR-29 family is highly ex-
pressed in somatic cells and decreases in expression during
somatic cell reprogramming (Figures 1A and 1B). Depletion
of miR-29 in fibroblasts dramatically changed the DNA
methylation status, suggesting that miR-29a is one of the
major miRNAs that maintains the DNAmethylation status
in fibroblasts (Figure 2). Previous studies showed that
DNMT3A and DNMT3B, as well as TET proteins, are targets
of the miR-29a family (Cheng et al., 2013; Hu et al., 2015).
Our data also demonstrated a strong inverse correlation
of the expression of the miR-29a family and the expression
of DNMTs and TETs. It is not yet clear which proteins
are direct targets of miR-29a in maintaining the DNA
methylation status in fibroblasts. However, the global
hypo-methylation upon miR-29a depletion suggests that
proteins involved in the DNA demethylation including
TETs and TDGs may be strong candidate targets (Figures
2A and 2B).
Previous studies implicated the miR-29a family in mouse
somatic cell reprogramming through different pathways
(Guo et al., 2013; Yang et al., 2011). Yang et al. (2011)
showed that suppression of miR-29a via Myc improves
the reprogramming by increasing p85alpha and CDC42,
thus suppressing the p53 pathway. Guo et al. (2013)
demonstrated that Sox2 is a critical factor inducing miR-
29b, and that ectopic overexpression of miR-29b improves
the reprogramming efficiency by suppressing Dnmt3a and
Dnmt3b. In reprogramming human somatic cells, we
found that suppression of the miR-29a family increased re-
programming efficiency. We also found that overexpres-Figure 4. miR-29a Depletion Promotes an ESC-Specific Epigeneti
(A) Hierarchical clustering of global DNA methylation profiles (MeDIP
closer to those in ESCs compared with control sponge and non-treate
(B–D) Heatmaps show DMRs in (B) TSS, (C) gene bodies, and (D) CpGI s
in developmental genes are hyper-methylated in Ctrl-sponge and non
(E) DMRs between ESC/29a-iPSC and control iPSC show enrichment in g
Pearson correlation coefficients between gene expression and DNA me
(p < 2.2 3 1016); CpGI, 0.020 (p = 0.038); and CpGI shore, 0.113 (sion of DNMT3B as well as TET1 improves reprogramming
efficiency. These seemingly contrasting results may be due
to the bidirectional global epigenetic changes accompa-
nying reprogramming. Not only DNA demethylation but
also de novo DNA methylation is found in reprogrammed
iPSCs (Lister et al., 2011). In light of the bidirectional epige-
netic regulation, the miR-29a seems to be a unique regu-
lator that potentially suppresses both de novo DNA meth-
yltransferases and demethylases, although miR-29a
depletion seems to have a more pronounced effect on
DNA demethylation in fibroblasts (Figures 2A and 2B).
miR-29a depletion could not replace MYC in a three- fac-
tor reprogramming attempt (data not shown), although it
improves reprogramming moderately but significantly
with four-factor reprogramming. MYC is a potent tran-
scription factor inducing and repressing a large number
of genes; suppression of miR-29a is one of many functions
of MYC during reprogramming (Yang et al., 2011). iPSC
lines, for which aberrant DNA methylation was reported,
were those derived from four-factor reprogramming (Lister
et al., 2011). Most likely, MYC expedites reprogramming
independent of its role in suppressing miR-29a. Expression
of DNA (de)methylation proteins via suppression of miR-
29a then becomes supplementary to the function of MYC
during reprogramming. When miR-29a targets are upregu-
lated at later stages of reprogramming, most loci are
already reprogrammed. Thus, the accessibility of TETs or
DNMT3A/B to target loci becomes limited, and thus epige-
netic reprogramming is limited in four-factorbased
reprogramming.
miRNAs are known to regulate the expression ofmultiple
targets via binding to 30 UTR. Our finding that the miR-29
family regulates global DNA methylation and demethyla-
tion adds another role to the list of common regulatory
roles of miRNAs. The miR-29 family was known to regulate
ECM proteins in physiological responses, such as systemic
sclerosis, hepatic fibrogenesis, and cardiac fibrosis (Hub-
macher and Apte, 2013; Kriegel et al., 2012; Zhang et al.,
2012). The ECM proteins are also important in pluripotent
stem cells. Laminin promotes stem cell renewal of ESCs in
feeder-free conditions (Xu et al., 2001), and a mixture of
human collagen, fibronectin, and laminin has been used
as animal-free culture conditions for ESCs (Ludwig et al.,
2006). Our transcriptome analysis in miR-29a-depletedc Profile in iPSCs
). TSS, gene body, and CpGI shore in -29abc sponge D551 iPSCs are
d iPSCs.
hore. GO analyses to genes neighboring DMRs show that CpGI shores
-treated iPSCs.
ene expression. *Denotes significance p < 0.05 by one-sided t test.
thylation level are TSS, 0.180 (p < 2.23 1016); gene body, 0.173
p < 2.2 3 1016).
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cells found changes in ECM proteins. Because the process
of mesenchymal-epithelial transition and the dynamic
changes in ECM proteins are highly coordinated during re-
programming, the miR-29 family seems likely to regulate
both the extracellular and intracellular epigenetic re-
sponses during reprogramming.
iPSC lines derived bymiR-29a depletion showed a similar
DNAmethylation status to that of ESCs (Figure 4). TSS, gene
body, and CpGI shore revealed the clustering of miR-29a
depleted iPSCs with ESCs, suggesting that miR-29a deple-
tion has a global impact on DNA methylation changes.
Gene expression showed a high correlation with DNA
methylation status (Figure 4E). Among the genes that ex-
press low in iPSCs compared with ESCs are some subtelo-
mericly located genes such as TCERG1L, TMEM132D, and
FAM19A5 (Lister et al., 2011).We found that the expression
these genes, particularly TCERG1L, is partially reactivated
by suppressing miR-29a. Investigation of the functional
relevance of miR-29a depletion on iPSCs, such
as developmental potential or epigenetic memory (Kim
et al., 2011), will be important in demonstrating the utility
of regulating miR-29a to derive clinically useful iPSCs.
Taken together, we identified miR-29a as an important
epigenetic regulator for somatic cells. The acquisition of
proper DNA methylation and hydroxymethylation states
in iPSCs is not optimal with current reprogramming
methods. We provide evidence that DNA methylation
undergoes rapid changes upon miR-29a depletion during
progression to pluripotency (Figure S4H). We believe that
the coordinated regulation of multiple DNA methylation
proteins by a miRNA family is a tool that will perfect the
epigenetic reprogrammingof iPSCs in future clinical utilities.EXPERIMENTAL PROCEDURES
Cell Culture, Reprogramming, and Modulation of
miR-29 Expression
Normal primary fibroblast D551 were maintained in DMEM high
glucose (Gibco) supplemented with 10% fetal bovine serum and
penicillin/streptomycin. Human ESCs and iPSCs were cultured
on irradiatedmurine embryonic feeder cells inmedium containing
DMEM/F12, 20% knockout serum replacement, and 4 ng/ml basic
fibroblast growth factor. Reprogramming was carried out using the
four human transcription factors OCT4, SOX2, KLF4, and MYC in
murine stem cell virus (pMSCV) retrovirus backbone as previously
described (Park et al., 2008). miR-29a mimic and antagomir were
purchased from Dharmacon. miR-29 sponge was generated as
described before (Cheng et al., 2013). Transfection was performed
using Lipofectamine.Gene Expression Analysis
Cells were lysed and RNA was isolated using an RNeasy Mini
Kit (Qiagen). Reverse transcription was performed using iScript52 Stem Cell Reports j Vol. 7 j 43–54 j July 12, 2016(Bio-Rad) according to the manufacturer’s protocol with primer
sets in Table S4A.
ChIP, RNA-Seq, hMeDIP-Seq, and Proteomics
Three days after infection with pMSCV retrovirus expression
reprogramming factors, cells were harvested for ChIP, RNA-seq,
hMeDIP-seq, bisulfite sequencing, or proteomics analysis. Total
RNA was extracted using a miRNeasy Mini Kit (Qiagen), and used
for qRT-PCR and RNA-seq. Genomic DNA was isolated from
D551 fibroblasts transfected with control and miR-29a antagomir
and processed for MeDIP and hMeDIP. RNA-seq, ChIP, hMeDIP-
seq, dot blot, and proteomics were performed as described in Sup-
plemental Experimental Procedures. Total reads andmapped reads
are listed in Table S4B.
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